stockrow
Wednesday 4 November 2026
Export ITRI’s income statement to Excel — free account
Itron, Inc.
ITRI Technology Scientific & Technical Instruments
Itron, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, down 3.02% from fiscal 2024.
- Revenue
- +3.04%
- EPS
- +13.8%
- Free cash flow
- −15.8%
- Total debt
- +26.5%
Quarter to September 2026, against a year earlier
101.54
3.32
+3.38%
Follow ITRI
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
14.03 | 14.05 | 14.21 | 13.73 |
P/S ratio |
1.78 | 1.71 | 1.66 | 1.63 | |
P/FCF ratio |
11.03 | 10.16 | 9.90 | 10.29 | |
P/Operating CF |
35.40 | 46.89 | 43.31 | 37.10 | |
P/B ratio |
2.43 | 2.46 | 2.33 | 2.20 | |
Price to Tangible BV |
13.63 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.88 | 2.27 | 2.22 | 2.15 | |
EV/EBITDA |
12.04 | 14.50 | 13.65 | 12.63 | |
EV/Operating CF |
10.97 | 12.71 | 12.43 | 12.61 | |
EV/FCF |
11.62 | 13.51 | 13.25 | 13.55 | |
Quick Ratio |
1.37 | 1.93 | 1.94 | 2.05 | |
Current Ratio |
1.80 | 2.66 | 2.75 | 2.83 | |
Net Debt/EBITDA |
2.43 | 9.79 | 8.59 | 6.36 | |
Debt/Assets |
33.55% | 39.56% | 39.44% | 38.31% | |
Debt/Equity |
0.72 | 0.97 | 0.96 | 0.92 | |
Asset Turnover |
0.66 | 0.63 | 0.60 | 0.59 | |
Operating CF/Net income |
1.17 | 1.60 | 1.65 | 1.43 | |
Capex/Depreciation |
(0.52) | (0.32) | (0.32) | (0.31) | |
Interest Coverage |
14.14 | 11.63 | 13.19 | 16.29 | |
Research and Development Expense of Revenue |
9.29% | 9.37% | 9.97% | 9.50% | |
Selling, General and Administrative Expense of Revenue |
16.67% | 17.95% | 15.94% | 14.03% | |
Intangible Assets out of Total Assets |
0.38 | 0.50 | 0.49 | 0.47 | |
Share Based Compensation of Revenue |
2.56% | 3.42% | 2.18% | 2.04% | |
Graham Net Nets |
(0.04) | (0.21) | (0.21) | (0.19) | |
Graham Number |
75.44 | 72.30 | 71.35 | 74.50 | |
Earnings Yield |
7.13% | 7.12% | 7.04% | 7.28% | |
Free Cash Flow Yield |
9.07% | 9.84% | 10.10% | 9.72% | |
Revenue per Share |
12.57 | 13.12 | 12.77 | 13.68 | |
Operating CF per Share |
2.62 | 1.91 | 2.00 | 2.33 | |
Capex per Share |
(0.17) | (0.15) | (0.15) | (0.15) | |
Free Cash Flow per Share |
2.45 | 1.77 | 1.85 | 2.18 | |
Cash per Share |
22.43 | 15.94 | 16.90 | 19.18 | |
Shareholders Equity per Share |
38.21 | 36.41 | 37.15 | 39.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
38.21 | 36.41 | 37.15 | 39.24 | |
Free Cash Flow |
111.51 | 78.97 | 81.49 | 95.55 | |
Working Capital |
810.09 | 951.06 | 985.30 | 1,088.50 | |
Capital Expenditures |
(7.81) | (6.53) | (6.60) | (6.41) | |
Net Current Asset Value |
(160.19) | (824.57) | (805.90) | (713.38) | |
EV/EBIT |
14.22 | 17.51 | 16.79 | 15.67 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
13.49 | 13.17 | 12.55 | 11.90 | |
| Other line items | |||||
Average Receivables |
359.13 | 369.88 | 345.72 | 374.79 | |
Average Payables |
150.61 | 168.67 | 134.93 | 169.64 | |
Average Inventory |
256.81 | 260.89 | 271.01 | 268.13 | |
Average Assets |
3,564.17 | 3,740.67 | 3,808.66 | 3,913.89 | |
Average Common Equity |
1,574.81 | 1,569.01 | 1,636.28 | 1,716.37 |
Columns are period end dates · fundamentals updated 2 Nov 2026